These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16387801

  • 1. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
    Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S.
    Am J Respir Crit Care Med; 2006 Mar 15; 173(6):673-82. PubMed ID: 16387801
    [Abstract] [Full Text] [Related]

  • 2. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.
    Davis IC, Lazarowski ER, Chen FP, Hickman-Davis JM, Sullender WM, Matalon S.
    Am J Respir Cell Mol Biol; 2007 Oct 15; 37(4):379-86. PubMed ID: 17541010
    [Abstract] [Full Text] [Related]

  • 3. Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.
    Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S.
    Am J Physiol Lung Cell Mol Physiol; 2004 Jan 15; 286(1):L112-20. PubMed ID: 12948936
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L, Mertz S, Gomez AM, Ramilo O, Wittke A, Mejias A.
    Antiviral Res; 2013 Aug 15; 99(2):188-95. PubMed ID: 23735300
    [Abstract] [Full Text] [Related]

  • 6. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Bolger G, Lapeyre N, Dansereau N, Lagacé L, Berry G, Klosowski K, Mewhort T, Liuzzi M.
    Can J Physiol Pharmacol; 2005 Feb 15; 83(2):198-213. PubMed ID: 15791294
    [Abstract] [Full Text] [Related]

  • 7. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice.
    Wolk KE, Lazarowski ER, Traylor ZP, Yu EN, Jewell NA, Durbin RK, Durbin JE, Davis IC.
    Am J Respir Crit Care Med; 2008 Nov 01; 178(9):969-76. PubMed ID: 18689466
    [Abstract] [Full Text] [Related]

  • 8. Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice.
    Aeffner F, Traylor ZP, Yu EN, Davis IC.
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul 01; 301(1):L99-L109. PubMed ID: 21478252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM, Wang Z, Kemble G, Duke G.
    PLoS One; 2015 Jul 01; 10(12):e0144648. PubMed ID: 26659560
    [Abstract] [Full Text] [Related]

  • 12. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
    Lambert AL, Mangum JB, DeLorme MP, Everitt JI.
    Toxicol Sci; 2003 Apr 01; 72(2):339-46. PubMed ID: 12655033
    [Abstract] [Full Text] [Related]

  • 13. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus).
    Grieves JL, Yin Z, Durbin RK, Durbin JE.
    Comp Med; 2015 Aug 01; 65(4):315-26. PubMed ID: 26310461
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
    Zhou J, Yang XQ, Xie YY, Zhao XD, Jiang LP, Wang LJ, Cui YX.
    Virus Res; 2007 Dec 01; 130(1-2):241-8. PubMed ID: 17804108
    [Abstract] [Full Text] [Related]

  • 15. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
    Lee JS, Lee YN, Lee YT, Hwang HS, Kim KH, Ko EJ, Kim MC, Kang SM.
    Nutrients; 2015 Feb 04; 7(2):1021-36. PubMed ID: 25658239
    [Abstract] [Full Text] [Related]

  • 16. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S, Dannenmaier J, Schild S, Macke O, Müller L, Burmeister Y, Seilheimer B, Müller M.
    PLoS One; 2018 Feb 04; 13(4):e0195822. PubMed ID: 29672626
    [Abstract] [Full Text] [Related]

  • 17. GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.
    Naessens T, Schepens B, Smet M, Pollard C, Van Hoecke L, De Beuckelaer A, Willart M, Lambrecht B, De Koker S, Saelens X, Grooten J.
    J Allergy Clin Immunol; 2016 Mar 04; 137(3):700-9.e9. PubMed ID: 26560044
    [Abstract] [Full Text] [Related]

  • 18. Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice.
    de Vrankrijker AM, Wolfs TF, Ciofu O, Høiby N, van der Ent CK, Poulsen SS, Johansen HK.
    J Med Virol; 2009 Dec 04; 81(12):2096-103. PubMed ID: 19856469
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
    Zang N, Li S, Li W, Xie X, Ren L, Long X, Xie J, Deng Y, Fu Z, Xu F, Liu E.
    Int Immunopharmacol; 2015 Sep 04; 28(1):121-8. PubMed ID: 26044349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.